Columnist Ahna Crum spent years trying to go it alone. Now she knows that freedom comes when she's flocking together with ...

AstraZeneca and Gilead are both staying tight-lipped over rumoured merger talks, but the consensus among analysts seems to be that there would anyway be little value in such a deal. On Sunday ...